SCHEMBL22453741

SCHEMBL22453741

O=Cc1ccccc1Nc1ccc(Nc2ccc(C34CC5CC(CC(C5)C3)C4)cc2)cc1

nearest known ligand 0.49

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ EPHX2 P34913 10/20 0.49
▸ NPC1 O15118 1/20 0.46
▸ LMNA P02545 3/20 0.41
▸ MAPT P10636 1/20 0.41
▸ ALDH1A1 P00352 1/20 0.41
▸ HIF1A Q16665 2/20 0.39
▸ EPAS1 Q99814 1/20 0.39
▸ SMN1; SMN2 Q16637 1/20 0.38
▸ GAA P10253 2/20 0.35
▸ PGR P06401 1/20 0.35
▸ HTT P42858 1/20 0.35
▸ NPSR1 Q6W5P4 1/20 0.35
▸ RCE1 Q9Y256 1/20 0.35
▸ MEN1 O00255 1/20 0.35
▸ POLB P06746 1/20 0.35
▸ GFER P55789 1/20 0.35
▸ KMT2A Q03164 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22452757 0.83 EPHX2 (0.49) EPHX2NPC1LMNAMAPTHIF1A
SCHEMBL22815320 0.79 EPHX2 (0.57) EPHX2NPC1LMNAMAPTALDH1A1
SCHEMBL22453102 0.79 EPHX2 (0.49) EPHX2NPC1LMNAMAPTALDH1A1
SCHEMBL31555348 0.77 HIF1A (0.60) EPHX2NPC1LMNAMAPTALDH1A1
SCHEMBL22452498 0.77 HIF1A (0.60) EPHX2NPC1LMNAMAPTALDH1A1
SCHEMBL22453281 0.77 HIF1A (0.44) EPHX2NPC1LMNAMAPTHIF1A
SCHEMBL22452479 0.76 EPHX2 (0.50) EPHX2NPC1LMNAMAPTHIF1A
SCHEMBL24421748 0.75 EPHX2 (0.53) EPHX2NPC1LMNAMAPTALDH1A1
SCHEMBL21670815 0.75 EPHX2 (0.53) EPHX2NPC1LMNAMAPTALDH1A1
SCHEMBL22161661 0.75 EPHX2 (0.53) EPHX2NPC1LMNAMAPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020190774-A1 NOVEL SMALL MOLECULE INHIBITORS OF TEAD TRANSCRIPTION FACTORS THE GENERAL HOSPITAL CORPORATION (US) 2020-09-24 — — WO disclosed
Send feedback